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Abstract:  We report the expression of Snail-1, E-cadherin and claudin-1 by indirect 
immunohistochemistry in colonic neoplasia. Snail-1 is a zinc finger transcription factor 
expressed in cells that already have undergone almost complete epithelial-mesenchymal 
transition (EMT) and have already evaded from the tumor. The main mechanism by which 
Snail induces EMT is downregulation of E-cadherin, of which expression was shown to be 
frequently downregulated in many different types of tumors, where it accompanies the 
invasiveness and metastatic behavior of malignant cells. Moreover, Snail-1 may 
downregulate the expression of claudin-1, a cell-cell adhesion protein which plays a likely 
role in progression and dissemination during tumorigenesis. Snail-1 was expressed in both 
carcinoma and adenoma cells with histologically normal epithelium in the mucosa, 
adjacent to the tumors, without significant differences, and predominant strong intensity of 
staining. Statistically significant differences were revealed between normal and tumorous 
epithelium (p = 0.003) at the subcellular level, where the shift of the protein to the 
cytoplasm with combined cytoplasmic/nuclear or pure cytoplasmic expression was 
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observed. E-cadherin expression was present in 100% of cases of both adenocarcinomas 
and adenomas, with prevailing strong membranous immunoreactivity and no differences 
between protein expression in tumors and normal mucosa. Predominating strong positivity 
of claudin-1 was detected in tumor cells of adenocarcinomas and adenomas. Marked 
differences were seen in protein localization, where membranous staining, typical for 
nontumorous epithelium, changed to combined membranous/cytoplasmic expression in 
adenocarcinomas (p = 0.0001) and adenomas (0.0002), in which cytoplasmic shift was 
associated with a higher degree of dysplasia. Furthermore, membranous/cytoplasmic 
localization was more frequent in the carcinoma group (87%) in comparison with 
adenomas (51%) (p = 0.0001). We conclude that dystopic subcellular localizations of 
Snail-1 and claudin-1 may participate in changes of cellular morphology and behavior 
which might be associated with altered effectory pathways of proteins and thus 
substantially contribute to the cancer development. 
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1. Introduction  
In recent years, research has shown that epithelial-mesenchymal transition (EMT) offers a relevant 
point for research. EMT refers to the process in which an epithelial cell disengages from its parent 
tissue by losing mediators of homotypic and/or heterotypic cell-cell interactions in exchange for 
morphology and adhesion marker profiles, consistent with a mesenchymal cell. It is regarded as the 
first necessary step for invasion and metastasis [1]. EMT is important in many developmental 
processes, playing crucial roles in the formation of the body plan and in the differentiation of multiple 
tissues and organs. Recently, a role for EMT in the process of cancer metastasis has been postulated. In 
carcinomas, aberrant activation of the process of EMT, by which cancer cells lose their polarity and 
are converted to a mesenchymal phenotype, is a late event in tumor progression; when cancer cells at 
the invasive front of primary tumors undergo a phenotypic conversion to invade and metastasize 
through the circulation and generate a metastatic lesion. The vast majority of known signaling 
pathways have been implicated in the regulation of EMT, from which a central role in this process is 
played by the transcriptional repressor Snail-1 [2]. Besides their involvement in EMT, Snail family 
members have been involved in a variety of other processes, such as apoptosis and left-right 
asymmetry. The Snail family includes Snail-1 (Snail), Snail-2 (Slug) and Snail-3 (Smuc), and has been 
shown to be over-expressed in a wide variety of human malignancies including oral [3], breast [4], 
hepatocellular [5], gastric [6], colon and skin carcinomas [7]. Snail-1 is a zinc finger transcription 
factor expressed in cells that already have undergone almost complete EMT and have already evaded 
from the tumor [8]. The observations presented so far associate Snail-1 with invasion, metastasis and 
poor prognosis [9]. The mechanism by which Snail-1 influences these different cellular processes 
remains largely unresolved. The main mechanism by which Snail-1 induces EMT is downregulation of 
E-cadherin [10,11] by direct repression of the protein through binding to E-boxes in the E-cadherin 
promoter [12].  Int. J. Mol. Sci. 2012, 13                 
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A loss of E-cadherin expression is considered to be a hallmark of EMT. E-cadherin, a key 
transmembrane molecule cell adhesion protein, is a member of a family of functionally related 
transmembrane glycoproteins that mediate Ca
2+-dependent intercellular adhesion. The adhesion is 
mediated via interaction with adjacent cells through their N-terminal ectodomains. The cytoplasmic 
terminal tail of E-cadherin links specifically to β-catenin that binds directly to cytoskeletal actin, which 
helps to assemble epithelial cell sheets. A loss of its expression or function diminishes cell-cell 
contacts, which leads to impaired intercellular signaling, but not to direct tumor transformation.   
E-cadherin expression was shown to be frequently downregulated in many different types of tumors, 
where it accompanies the invasiveness and metastatic behavior of malignant cells [13]. 
Besides adherent junctions (AJs), cell-cell adhesions are maintained through tight junctions (TJs). 
In contrast to the role of AJs, the role of TJ proteins in cancer is less well understood. TJs are the most 
apical cell-cell contacts and are important for a barrier function that regulates the passage of ions, 
water, and macromolecules, together with a fence function that maintains cell polarity. A number of 
integral membrane proteins associated with TJs have been identified, including the claudin family 
consisting of at least 24 members, of which claudin-1 was also recently identified as a probable target 
of β-catenin/Tcf signaling. In colorectal cancer (CRC), different data have been published concerning 
claudin-1 expression in cancer cells. On the one hand, claudin-1 upregulation was described at both 
RNA and protein levels [14,15]. On the other hand, reduced claudin-1 expression was shown to 
correlate with poor differentiation, disease recurrence and poor patient survival [16]. It has been shown 
that Snail-1 may downregulate the expression of claudin-1 [17]. Another study emphasizes the role of 
E-cadherin expression and localization in the claudin-1 dependent regulation of EMT, suggesting that 
claudins play a role in progression and dissemination during tumorigenesis [15].  
The goal of this study is to report the expression of Snail-1, E-cadherin and claudin-1 in colonic 
neoplasia, as colorectal tumors provide an excellent system to study the genetic alterations involved in 
the development of common human neoplasms [18]. Despite the fact that many data concerning 
similar topics have been published up to now, their results often vary. Moreover, little is known about 
stromal protein expression and its impact on colon cancerogenesis. 
2. Results  
2.1. Snail-1 
The protein was expressed in high levels without significant differences between carcinomas, 
adenomas and histologically normal epithelium in the mucosa adjacent to the tumors. Snail-1 protein 
was also evaluated in adenocarcinomas according to their grade. Interestingly, 10% of grade 3 tumors 
showed a decrease in expression from strong to weak (p = 0.009). Within nontumorous colon epithelium, 
Snail-1 was localized predominantly in the base of crypts; superficial areas exhibited weaker intensity 
or were negative. Statistically significant differences were revealed between normal and tumorous 
epithelium (p = 0.003) at the subcellular level, where the shift of the protein to the cytoplasm with 
combined cytoplasmic/nuclear or pure cytoplasmic expression was observed (Figure 1). In nontumorous 
cells of the epithelium, pure nuclear positivity predominated (57% of cases), while combined 
cytoplasmic/nuclear was detected in 34% and cytoplasmic in only 5% of cases. In carcinomas and Int. J. Mol. Sci. 2012, 13                 
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adenomas, combined cytoplasmic/nuclear expression prevailed (64% of cases), pure nuclear 
expression was observed in 4%, and 32% of cases exhibited only cytoplasmic protein distribution. 
Moreover, Snail-1 was detected in the stromal elements fibroblasts, endothelial cells and 
macrophages (Figure 2). Stromal elements in adenocarcinomas exhibited statistically higher levels   
(p < 0.0001) of nuclear Snail-1 positivity compared with the adjacent nontumorous stromal elements. 
Stroma of adenocarcinomas expressed significantly higher levels of Snail-1 when correlated with 
stroma of adenomas (p = 0.012). Interestingly, stroma of mucosa adjacent to adenocarcinomas showed 
higher numbers of Snail-1 positive elements when compared to normal mucosa close to adenomas  
(p = 0.031). There were no differences between stroma of adenomas and normal mucosa. 
Figure 1. Cellular localization of Snail-1. 
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Figure 2. Immunohistochemical staining of Snail-1. (a) Nuclear expression in normal 
colonic epithelium; (b) Combined nuclear/cytoplasmic expression, with predominating 
nuclear localization in adenoma; (c) Combined nuclear/cytoplasmic expression in 
adenocarcinoma; (d) Purely cytoplasmic expression in adenocarcinoma. 
 
 Int. J. Mol. Sci. 2012, 13                 
 
 
1636
2.2. E-cadherin 
E-cadherin expression was present in 100% of cases of both adenocarcinomas and adenomas, with 
prevailing strong immunoreactivity (Figure 3). There were no differences between protein expression 
in tumors and normal mucosa. E-cadherin expression in adenocarcinomas was detected to be mostly 
strong in G2 and G3 tumors. G1 tumors covered significantly more patients with moderate expression  
(p = 0.026). The analysis did not show statistically significant differences in E-cadherin expression 
between neoplastic cells and normal epithelium. E-cadherin was localized on cell membranes and no 
changes in subcellular localization were found. 
Figure 3. Immunohistochemical staining of E-cadherin. (a) Strong membranous 
expression in adenoma; (b) Moderate membranous expression in adenocarcinoma. 
 
2.3. Claudin-1 
In tumor cells of adenocarcinomas and adenomas, prevailing strong positivity of claudin-1 was 
detected, without significant quantitative differences between the two groups. Claudin-1 was expressed 
in significantly higher levels in adenomas (p = 0.034) and adenocarcinomas (p = 0.005), comparing 
with normal epithelium. No differences were observed concerning the grade of carcinomas. Marked 
differences were seen in protein localization (Figure 4), where membranous staining, typical for 
nontumorous epithelium, changed to combined membranous/cytoplasmic expression in 
adenocarcinomas (p = 0.0001) and adenomas (0.0002), where cytoplasmic shift was associated with a 
higher degree of dysplasia. Furthermore, membranous/cytoplasmic localization was more frequent in 
the carcinoma group (87%) in comparison with adenomas (51%) (p = 0.0001). 
In stromal elements, claudin-1 was not regularly present (Figure 5). In all groups (benign mucosa, 
adenomas, adenocarcinomas), there were negative cases. In adenocarcinomas, however, a significant 
increase in the number of positive elements was observed compared to normal mucosa (p < 0.012). 
Figure 4. Cellular localization of claudin-1.  
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Figure 5. Immunohistochemical staining of claudin-1. (a) Membranous expression in 
normal epithelium; (b) Strong membranous expression in adenoma; (c) Combined 
membranous/cytoplasmic expression in adenocarcinoma; (d) Cytoplasmic expression   
in adenocarcinoma. 
 
3. Discussion 
The purpose of this study was to report the changes of immunohistochemical expression and their 
localization of Snail-1, E-cadherin and claudin-1, proteins substantially involved in EMT of colon 
mucosa. EMT refers to the process whereby an epithelial cell disengages from its parent tissue by 
losing mediators of homotypic and/or heterotypic cell-cell interactions in exchange for morphology 
and adhesion marker profiles consistent with a  mesenchymal cell. Generally, as EMT promotes 
invasion of cancer cells and metastasis, it is associated with worse prognosis for cancer patients [1]. 
However, despite recent advances, much remains unknown about the EMT program in cancer 
progression and metastasis, because cancer is a complex and multistep process, and EMT represents 
only a part of the process of tumor progression. Snail-1 is a transcriptional factor whose 
overexpression was shown to be important in intestinal tumorigenesis [19]. The Snail family is 
activated by multiple signaling pathways, including Wnt/β-catenin, TGF-β ( transforming growth   
factor β), TNF-α (tumor necrosis factor α), RAS, ILK (integrin-linked kinase), NF-κB (nuclear factor  
κ-light-chain-enhancer of activated B cells), HIF (hypoxia-inducible factor), AKT activation and 
EGFR (epidermal growth factor receptor) signaling [20,21]. Varying data have been published 
concerning Snail expression in cancer cells and nontumorous epithelium. While Franci et al. (2009) 
described the protein only in carcinoma cells [8], Zhu et al. (2010) found Snail-1 expression in normal 
epithelium [22]. Similarly, in our study, the protein was detected in normal colon epithelium, where it 
was mostly bound to crypts. Thus, we concluded that Snail-1 may not necessarily be associated with 
malignant transformation, but might act by maintenance of a balance between cell proliferation, 
differentiation and apoptosis. Snail-1 is typically localized in the nucleus. However, the subcellular 
localization and stability are sensitive to Ser/Thr phosphorylation, when after being phosphorylated, 
Snail-1 is translocated to the cytosol, where it is not active and is subsequently degraded [8,23]. Int. J. Mol. Sci. 2012, 13                 
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Phosphorylated Snail-1 is much less active as a repressor of E-cadherin transcription or as an activator 
of the expression of mesenchymal genes. When phosphorylated, Snail-1 retains the ability to bind 
DNA, so phosphorylation seems to block its access to the target promoter. Phosphorylation of Snail-1 
is controlled by cellular attachment to the ECM, so extracellular environment may regulate its   
activity [23]. However, cytoplasmic localization of the protein might not be definitively associated 
with loss of its function. The possibility that cytoplasmic Snail-1 plays a positive role in the acquisition 
of migratory abilities by tumor cells cannot be totally discarded. We demonstrated increasing Snail-1 
expression in stromal fibroblasts, macrophages and endothelial cells in adenomas and adenocarcinomas, 
confirming that such expression may play a substantial role in cancer progression. The mechanism by 
which Snail-1 in stroma may influence tumor growth is not fully understood. One possible explanation 
is immunosuppression through immunosuppressive cytokines, regulatory T cells, impaired dendritic 
cells and cytotoxic T lymphocyte resistance [24]. The presence of Snail-1 immunoreactive cells in the 
stroma may be an informative indicator of prognosis of colon tumors. It has been shown that 
intratumoral injection with a Snail-specific monoclonal antibody inhibits tumor growth and metastasis 
followed by an increase of tumor-specific tumor-infiltrating lymphocytes and systemic immune 
response [25]. Snail-1 is one of the strongest repressors of E-cadherin through binding to E-boxes in 
the E-cadherin promoter [10,11]. E-cadherin is important for epidermal intercellular adherence and 
loss of E-cadherin-mediated cell adhesion and is one rate-limiting step in the progression from 
adenoma to carcinoma [26,27]. Dysfunction or disruption of cell adhesion molecules also accompanies 
the invasiveness and metastatic behavior of malignant cells, when loss of E-cadherin consistently 
occurs at sites of EMT during cancer development. E-cadherin downregulation is commonly described 
in colorectal adenocarcinomas. However, in our study we revealed neither a decrease in protein levels 
nor its cytoplasmic shift from the membrane, and the protein expression did not differ from 
nontumorous epithelium. 
Considering our findings, E-cadherin presence in CRC either caused no alteration of AJs or 
intercellular signaling may be at least partly E-cadherin independent. For example, Snail-1 can 
functionally interact with catenin and directly enhance the activation of Wnt signaling, thus 
establishing a positive feedback loop for Wnt-dependent transcription [28]. It has also been documented 
that Wnt and EGFR signaling pathways cross-talk mutually, and transactivation of each other has been 
described, so activation of catenin with a downstream effector of Wnt pathway can be mediated via 
EGFR. Also despite the fact that previous studies demonstrated a considerable inverse correlation 
between E-cadherin and Snail-1 mRNA levels in most epithelial tumor cell lines [3,7,10,11], 
Domínguez et al. (2003) reported simultaneous expression of E-cadherin and Snail-1 when detected in 
similar protein levels [23]. However, these facts deserve further investigation. 
Snail-1 is a known suppressor of TJ proteins, of which claudin-1 was involved in our study.   
TJs belong to key molecular components governing cellular adhesion and polarity. Since in   
neoplastic cells, the expression of intestinal epithelial TJ proteins frequently exhibit structural and  
functional altrations, they might contribute to neoplastic progression via induction of epithelial   
dedifferentiation [29,30].  
Differing data have been published concerning claudin-1 expression in colon tumors, describing 
both downregulation as well as overexpression of the protein. More frequently increased protein levels 
were found in adenomas and adenocarcinomas [15,31,32]. Low expression of claudin-1was correlated Int. J. Mol. Sci. 2012, 13                 
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with higher tumor grades, acquisition of a metastatic phenotype and poor patient survival. Moreover, 
decreased claudin-1 expression has even been suggested to be a stronger predictor of recurrence and  
survival [16]. It is not well understood which factors, apart from Snail-1, are involved in dysregulation 
of claudin-1 expression. Growth factors EGF and TGF-beta may upregulate the protein levels. 
Claudin-1 was also identified as a target of beta-catenin/Tcf signaling pathway [15]. In our study, 
immunohistochemistry confirmed elevated expression level of claudin-1 both in adenomas, in 
particular adenomas with severe dysplasia, as well as in CRC, when compared to normal adjacent 
mucosa. We did not confirm loss of protein expression in G3 adenocarcinomas. As claudins regulate 
paracellular transport, they are usually found at the cell membrane. In concordance with other studies, 
we found predominantly a circumferential membranous pattern of staining for claudin-1 in normal 
colonic epithelium. However, in tumor lesions, claudin-1 exhibited dysregulated subcellular 
localization with moving away from its typical membranous position. Claudin-1 remained located on 
the cytoplasmic membranes mainly in adenomas without or with mild dysplasia, whereas the shift to 
the cytoplasm with cytoplasmic or membranous/cytoplasmic expression was observed in high-grade 
dysplastic adenomas and carcinomas. However, a minority of the tumors preserved cytoplasmic 
staining as well. We did not confirm the nuclear localization of claudin-1 [15]. The importance of 
claudin-1 mislocalization is not fully understood. Cytoplasmic claudin-1 localization is associated with 
induction of EMT, resulting in increased cell motility and metastatic potential. Loss of membranous 
expression may also stimulate tumor growth non-specifically, when alteration of TJ-regulated 
permeability may allow increased diffusion of nutrients and other factors critical for tumor growth and 
survival. Furthermore, claudins have been reported to recruit and promote the activation of MMP-2 
(matrix metalloproteinase-2), suggesting potential involvement in invasion and metastasis.  
Little is known about mechanisms affecting subcellular claudin-1 localization. It has been reported 
that protein kinases such as protein kinase A (PKA) and protein kinase C (PKC) are important for the 
regulation and cytoplasmic localization of claudin-1 expression [33,34]. The significance of claudin-1 
in the nucleus is unclear. It is known that the nuclear expression of other TJs can either inhibit 
proliferation, or on the other hand may correlate with oncogenic transformation and proliferation. Only 
few data have been published concerning claudin expression in stromal elements. Claudin-1 expression 
has been described in immune cells, monocytes and lymphocytes, in association with their   
activation [35]. Claudin-1was detected in endothelial cells. Both decrease of its expression or 
overexpression may be associated with altered permeability [36,37].  
We found the protein in endothelial cells, macrophages and lymphocytes, with only scattered 
elements being present within normal epithelium. An increased number of positive cells were found in 
adenomas and especially in carcinomas. It is not clear whether such expression influences tumor 
growth positively or negatively.  
4. Material and Methods 
4.1. Immunohistochemistry 
Archival cases of grade 1 to 3 colon carcinomas from 120 consecutive patients and 42 samples of 
adenomas were retrieved from the archives of the Department of Clinical and Molecular Pathology, Int. J. Mol. Sci. 2012, 13                 
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Faculty of Medicine and Dentistry, Palacky University Olomouc between 2007 and 2010. First, the 
corresponding H&E slides were reviewed by a pathologist to confirm the diagnosis and adequacy of 
material. All selected tissue samples were formalin fixed and paraffin embedded. 
Immunohistochemistry for Snail-1, E-cadherin and claudin-1 was performed on 5-µm   
paraffin-embedded colorectal cancer tissue section. The slides were stained with antibodies: Snail-1 
(rabbit polyclonal, Ab 85931, 1:150, Abcam), E-cadherin (mouse monoclonal, M3612, 1:50, Dako) 
and claudin-1 (mouse monoclonal, sc-81796, 1:500, Santa Cruz Biotechnology, Inc.) by an indirect 
immunohistochemical method using the BenchMark XT immunostainer (Ventana Medical   
Systems, Inc.). 
The quality and intensity of staining as well as cellular localization were evaluated in tumor cells 
and the surrounding tumor stroma. Moreover, normal epithelium and its surrounding stroma were also 
assessed in each sample. Evaluation of protein expression was done by a modified H-score, in which 
both intensity and proportion of staining were categorized from 0 to 3. 
Cell positivity was multiplied by intensity of staining to form a multiplicative score. The cases were 
sorted into four subgroups: Hscore 0 referred to negative expression; Hscore 12 to weak expression; 
Hscore 35 to moderate expression; and Hscore 69 to strong expression. 
4.2. Statistical Analysis 
The staining of protein expression in neoplastic cells was compared to that of normal epithelium 
and tumor grade. Furthermore, tumor stroma was compared to the surrounding stroma of normal 
epithelium and protein levels were also compared between adenomas and adenocarcinomas. The 
assessment was evaluated by Fisher’s exact test. Associations between binary categories were analyzed 
using the chi-square test. P-values of 0.05 or less were considered to be statistically significant. 
5. Conclusions 
In summary, we demonstrated that not only overexpression of both Snail-1 and claudin-1 is 
involved in transformation of colonic epithelium, but also changes in subcellular localizations, when 
predominantly cytoplasmic Snail-1 and claudin-1 expression might be important for malignant 
transformation and might substantially contribute to the cancer development. Our findings deserve 
further morphological as well as functional investigation. 
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